| Quarter (USD) | Sep 20 | Jun 20 | Mar 20 | Sep 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 19 | Dec 18 | |
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Operating income | |||
| Operating margin | |||
| Net income | |||
| Net profit margin | |||
| Cash on hand | |||
| Change in cash | |||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 162 |
| Opened positions | 37 |
| Closed positions | 18 |
| Increased positions | 50 |
| Reduced positions | 45 |
| 13F shares | Current |
|---|---|
| Total value | 518.27 bn |
| Total shares | 69.30 mm |
| Total puts | 1.46 mm |
| Total calls | 1.51 mm |
| Total put/call ratio | 1.0 |
| Largest owners | Shares | Value |
|---|---|---|
| Caligan Partners | 8.12 mm | $81.19 bn |
| Patient Square Capital | 7.18 mm | $71.83 bn |
| Legend Aggregator | 7.18 mm | $88.02 mm |
| BlackRock | 4.21 mm | $42.06 bn |
| Vanguard | 3.44 mm | $34.42 bn |
| Farallon Capital Management | 3.29 mm | $32.91 bn |
| Findell Capital Management | 3.19 mm | $31.94 bn |
| Canaan VIII | 2.92 mm | $0.00 |
| New Enterprise Associates 12, Limited Partnership | 2.53 mm | $0.00 |
| Kynam Capital Management | 2.27 mm | $22.66 bn |
